Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.83
-$0.03-3.49%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.51% | 5.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.51% | 5.48% | |||
| Cost of Revenue | 5.13% | -1.13% | |||
| Gross Profit | 10.46% | 9.71% | |||
| SG&A Expenses | 13.90% | 13.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -199.75% | -102.61% | |||
| Total Operating Expenses | 9.77% | 4.41% | |||
| Operating Income | 3.75% | 9.75% | |||
| Income Before Tax | -14.14% | 14.62% | |||
| Income Tax Expenses | 10.88% | -37.54% | |||
| Earnings from Continuing Operations | -21.70% | 53.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.70% | 53.30% | |||
| EBIT | 3.75% | 9.75% | |||
| EBITDA | 3.68% | 8.38% | |||
| EPS Basic | -23.05% | 54.95% | |||
| Normalized Basic EPS | -15.28% | 14.50% | |||
| EPS Diluted | -23.05% | 54.95% | |||
| Normalized Diluted EPS | -15.28% | 14.50% | |||
| Average Basic Shares Outstanding | 1.61% | -0.84% | |||
| Average Diluted Shares Outstanding | 1.61% | -0.84% | |||
| Dividend Per Share | -- | 1.83% | |||
| Payout Ratio | 0.32% | -0.34% | |||